vTv Therapeutics Inc. (VTVT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 15M 30M 45M Q3 '21: 3M Q4 '21: 9K Q1 '22: 2M Q2 '22: 9K Q3 '22: 0 Q4 '22: 9K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 1M Q2 '24: 0 Q3 '24: 0 Q4 '24: 17K Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 36.8M Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-16M -8M 0 8M 16M 24M Q3 '21: -1.6M Q4 '21: -11.1M Q1 '22: -6.5M Q2 '22: -4M Q3 '22: -5.7M Q4 '22: -6.3M Q1 '23: -7.4M Q2 '23: -8M Q3 '23: -5.4M Q4 '23: -4.7M Q1 '24: -5.6M Q2 '24: -7.2M Q3 '24: -6.5M Q4 '24: -4.9M Q1 '25: -6.5M Q2 '25: -7.7M Q3 '25: -10.7M Q4 '25: -7.9M Q1 '26: 23.3M Q2 '26: -13.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-18M -9M 0 9M 18M 27M Q3 '21: -1.1M Q4 '21: -7.1M Q1 '22: -7M Q2 '22: -3.2M Q3 '22: -4.3M Q4 '22: -4.7M Q1 '23: -4.5M Q2 '23: -5.6M Q3 '23: -6.7M Q4 '23: -3.5M Q1 '24: -4.9M Q2 '24: -5.2M Q3 '24: -4.8M Q4 '24: -3.6M Q1 '25: -5.1M Q2 '25: -6M Q3 '25: -8.7M Q4 '25: -7.1M Q1 '26: 24.1M Q2 '26: -13.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '21: -3.6M Q4 '21: -6.4M Q1 '22: -1M Q2 '22: 706K Q3 '22: -8.8M Q4 '22: -6.9M Q1 '23: -5.2M Q2 '23: -6.2M Q3 '23: -4.8M Q4 '23: -2.9M Q1 '24: -7.3M Q2 '24: -6.7M Q3 '24: -6.4M Q4 '24: -4.8M Q1 '25: -5.7M Q2 '25: -5.1M Q3 '25: -5.2M Q4 '25: -9.3M Q1 '26: 9.2M Q2 '26: -11.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-15M -10M -5M 0 5M 10M 15M Q1 '15: -9.4M Q2 '15: -8.8M Q3 '15: -9.8M Q4 '15: -9M Q3 '16: -12.7M Q4 '16: -11.4M Q1 '17: -13.9M Q2 '17: -12.6M Q3 '17: -11.8M Q4 '17: -6.3M Q4 '18: -5.9M Q3 '21: -3.6M Q4 '21: -6.4M Q3 '22: -8.8M Q4 '22: -6.9M Q3 '23: -4.8M Q4 '23: -2.9M Q2 '15 Q3 '16 Q2 '17 Q4 '18 Q3 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.